| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/15/2014 | CN103517901A 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 01/15/2014 | CN103517896A Quinolinone derivatives |
| 01/15/2014 | CN103509042A Preparation method of new terbium complex probe and applications of new terbium complex probe used as potassium ion recognition reagent |
| 01/15/2014 | CN103509010A Organic light-emitting compound and organic light-emitting device including the same |
| 01/15/2014 | CN103508961A Antitumor drug |
| 01/15/2014 | CN103508957A Hydroxyethyl pyrazole compound or aminoethyl pyrazole compound, preparation method and use thereof |
| 01/15/2014 | CN103508950A 4-hydroxy-2-quinolinone compounds containing imine structure, and preparation and application thereof |
| 01/15/2014 | CN102159570B Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 01/14/2014 | US8629277 Styrenyl 1,2,4-oxadiazole compounds |
| 01/14/2014 | US8629168 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 01/14/2014 | US8629165 Methods for treating cognitive disorders |
| 01/14/2014 | US8629157 Pyrrolidine compounds which modulate the CB2 receptor |
| 01/14/2014 | US8629156 Tryptophan hydroxylase inhibitors |
| 01/14/2014 | US8629138 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/14/2014 | US8629137 CGRP antagonists |
| 01/14/2014 | US8629132 Kinase inhibitors |
| 01/09/2014 | WO2014008257A2 Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles |
| 01/09/2014 | WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors |
| 01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/09/2014 | WO2014006250A1 Use of sulphated glycolipids as promoters of neuritic growth and myelination and inhibitors of the proliferation of astroglia and microglia |
| 01/09/2014 | US20140012010 Method for producing optically active compound or salt thereof |
| 01/09/2014 | US20140011997 Neprilysin inhibitors |
| 01/09/2014 | US20140011996 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 01/09/2014 | US20140011988 Dibenzo[B,F][1,4]Oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors |
| 01/09/2014 | US20140011823 Novel phenylpyridine derivative and drug containing same |
| 01/09/2014 | US20140011808 1,2-disubstituted heterocyclic compounds |
| 01/09/2014 | US20140011807 Nitrogen-containing saturated heterocyclic compound |
| 01/09/2014 | US20140011796 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | US20140011758 Isoxazoline derivatives as antiparasitic agents |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | CA2876215A1 Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles |
| 01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
| 01/08/2014 | EP2681216A2 Substituted 6,5-fused bicyclic heteroaryl compounds |
| 01/08/2014 | EP2681206A1 Mst1 kinase inhibitors and methods of their use |
| 01/08/2014 | EP2681200A1 Benzimidazole inhibitors of the sodium channel |
| 01/08/2014 | EP2681198A1 Novel small-molecules as therapeutics |
| 01/08/2014 | EP2681195A1 Novel kinase inhibitors |
| 01/08/2014 | EP2681194A1 3-amino-pyridines as gpbar1 agonists |
| 01/08/2014 | EP2680840A1 Novel benzodioxole piperidine compounds |
| 01/08/2014 | EP2680697A1 Process for the preparation of an orexin receptor antagonist |
| 01/08/2014 | CN103502246A Isoxazole derivatives |
| 01/08/2014 | CN103502240A Azole derivative |
| 01/08/2014 | CN103502227A 1,3 oxazines as bace1 and/or bace2 inhibitors |
| 01/08/2014 | CN103502226A Cycloalkenyl aryl derivatives for CETP inhibitor |
| 01/08/2014 | CN103502219A Novel small-molecules as therapeutics |
| 01/08/2014 | CN103501615A Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi |
| 01/08/2014 | CN103497181A Benzoperhydroazepinone compounds as glycogen phosphorylase inhibitors as well as preparation method and medical application thereof |
| 01/08/2014 | CN103497173A Novel compound having heterocyclic ring |
| 01/08/2014 | CN103497148A Hydroxylamine compounds and methods of their use |
| 01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
| 01/08/2014 | CN101903349B 4-(4-pyridinyl)-benzamides and application thereof as ROCK activity modulators |
| 01/08/2014 | CN101541781B Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 01/08/2014 | CN101426772B Benzotriazine inhibitors of kinases |
| 01/07/2014 | US8624025 Antiviral agents |
| 01/07/2014 | US8623945 Use of oligomeric carbodiimides as stabilizers |
| 01/07/2014 | US8623892 Metalloenzyme inhibitor compounds |
| 01/07/2014 | US8623883 4-phenylamino-quinazolin-6-yl-amides |
| 01/07/2014 | US8623877 Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 01/07/2014 | US8623875 Isoxazoline insecticides |
| 01/07/2014 | US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 01/07/2014 | US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |
| 01/07/2014 | US8623860 Azetidine derivatives, pharmaceutical compositions and uses thereof |
| 01/07/2014 | US8623857 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 |
| 01/07/2014 | US8623844 Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations |
| 01/07/2014 | CA2624310C Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 01/03/2014 | WO2014005122A2 Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration |
| 01/03/2014 | WO2014003424A1 Novel rebamipide prodrug, method for producing same, and usage thereof |
| 01/03/2014 | WO2014003124A1 Novel amide derivative and salt thereof |
| 01/03/2014 | WO2014002106A1 Novel compounds for the treatment of dyslipidemia and related diseases |
| 01/03/2014 | WO2014001247A1 N-[4-(Quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | WO2014001228A1 Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors |
| 01/03/2014 | WO2012145737A8 Fatty acid amide hydrolase inhibitors for treating pain |
| 01/03/2014 | CA2877786A1 N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/02/2014 | US20140005382 Nitrogen-containing condensed heterocyclic compound |
| 01/02/2014 | US20140005221 Ring-fused compound |
| 01/02/2014 | US20140005212 Substituted Pyridines as Sodium Channel Blockers |
| 01/02/2014 | US20140005181 Small molecule antagonists of the apelin receptor for the treatment of disease |
| 01/02/2014 | US20140005178 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/02/2014 | US20140005172 Benzoxazepines as Inhibitors of PI3K/M TOR and Methods of Their Use and Manufacture |
| 01/02/2014 | US20140005165 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
| 01/02/2014 | US20140005164 Wnt pathway antagonists |
| 01/02/2014 | US20140005150 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/02/2014 | US20140005143 Substituted PyridineCompound |
| 01/02/2014 | US20140001443 Organic light-emitting compound and organic light-emitting device including the same |
| 01/01/2014 | EP2679585A1 Glycine transport inhibitor |
| 01/01/2014 | EP2678332A2 Diaminopyrimidine derivatives and processes for the preparation thereof |
| 01/01/2014 | EP2678331A2 Diaminopyrimidine derivatives and processes for the preparation thereof |
| 01/01/2014 | EP2678315A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR |
| 01/01/2014 | CN103492372A Androgen receptor modulating carboxamides |
| 01/01/2014 | CN103492368A Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| 01/01/2014 | CN103483345A Phosphoinositide 3-kinase (P13K) inhibitor, pharmaceutical composition containing P13K inhibitor, and application of phosphoinositide kinase inhibitor and pharmaceutical composition |
| 01/01/2014 | CN103483331A Preparation method for maleimide-containing biphenol type benzoxazine |
| 01/01/2014 | CN103483330A Energy containing ionic salts of 4, 4'-bi [3, 3'-(1-H-5-tetrazolium)] furazan and preparation method thereof |
| 01/01/2014 | CN103483329A Furanone-aryl-oxazolidinone type compound as well as preparation method and application thereof |
| 01/01/2014 | CN103483328A Stilbene fluorescent whitening agent, and preparation method and application thereof |
| 01/01/2014 | CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 01/01/2014 | CN102285931B Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-bezisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |